PAULA REYES: Open Payments
NPI 1649933979 · SUPPLY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 65 payments from 13 companies in 2025. Trend: 2023 $1,253 · 2024 $1,423 · 2025 $1,210
Food & beverage: $1,110Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $294 |
| UCB, Inc. | 12 | $187 |
| Regeneron Healthcare Solutions, Inc. | 6 | $156 |
| Novartis Pharmaceuticals Corporation | 9 | $156 |
| ABBVIE INC. | 10 | $139 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| GENZYME CORPORATION | 2 | $52 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: TREMFYA, DUPIXENT, Bimzelx, ILUMYA, COSENTYX, SKYRIZI, RINVOQ, Sotyktu.
Industry payments across NC — which companies pay providers there.
